Burning Rock Biotech (BNR) Cash & Equivalents: 2020-2024
Historic Cash & Equivalents for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $71.2 million.
- Burning Rock Biotech's Cash & Equivalents fell 25.65% to $65.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.2 million, marking a year-over-year decrease of 25.65%. This contributed to the annual value of $71.2 million for FY2024, which is 17.79% down from last year.
- Per Burning Rock Biotech's latest filing, its Cash & Equivalents stood at $71.2 million for FY2024, which was down 17.79% from $86.6 million recorded in FY2023.
- Over the past 5 years, Burning Rock Biotech's Cash & Equivalents peaked at $290.5 million during FY2020, and registered a low of $71.2 million during FY2024.
- In the last 3 years, Burning Rock Biotech's Cash & Equivalents had a median value of $86.6 million in 2023 and averaged $96.4 million.
- In the last 5 years, Burning Rock Biotech's Cash & Equivalents plummeted by 41.55% in 2022 and then grew by 17.79% in 2024.
- MRY analysis of 5 years shows Burning Rock Biotech's Cash & Equivalents stood at $290.5 million in 2020, then fell by 22.68% to $224.6 million in 2021, then crashed by 41.55% to $131.3 million in 2022, then crashed by 34.01% to $86.6 million in 2023, then dropped by 17.79% to $71.2 million in 2024.
- Its last three reported values are $71.2 million in FY2024, $86.6 million for FY2023, and $131.3 million during FY2022.